Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RYTM
RYTM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RYTM News
Stock Investment Opportunities in May
4d ago
Fool
Rhythm Pharmaceuticals Reports Strong Earnings, IMCIVREE Demand Surges
4d ago
Newsfilter
Rhythm Pharmaceuticals Surges 8% After Strong Quarterly Earnings Report
5d ago
Fool
Rhythm Pharmaceuticals Q1 2026 Earnings Call Highlights
5d ago
seekingalpha
RHYTHM PHARMACEUTICALS STOCK JUMPS 7.5% IN PREMARKET TRADING FOLLOWING Q1 REVENUE INCREASE
5d ago
moomoo
Rhythm Pharmaceuticals Q1 2026 Earnings Report Analysis
5d ago
seekingalpha
Rhythm Pharmaceuticals to Announce Q1 Earnings on May 5
6d ago
seekingalpha
Rhythm Pharmaceuticals Expands IMCIVREE Approval in Europe
6d ago
NASDAQ.COM
RHYTHM PHARMACEUTICALS UNVEILS NEW DATA ON ACQUIRED HYPOTHALAMIC OBESITY AT PEDIATRIC ENDOCRINE SOCIETY CONFERENCE
6d ago
moomoo
Rhythm Pharmaceuticals Secures EU Approval for Novel Therapy
May 01 2026
Yahoo Finance
Rhythm Pharmaceuticals Appoints New Board Member
Apr 03 2026
NASDAQ.COM
Rhythm Pharmaceuticals Gains FDA Approval for Expanded Market
Mar 31 2026
Fool
Rhythm Pharmaceuticals Receives EMA Support for Imcivree Label Expansion
Mar 26 2026
seekingalpha
Rhythm Pharmaceuticals Receives Positive EMA Opinion for IMCIVREE Expansion
Mar 26 2026
Newsfilter
PANTHERx Selected as Exclusive U.S. Pharmacy Partner for IMCIVREE Distribution
Mar 20 2026
PRnewswire
PANTHERx Selected as Exclusive U.S. Pharmacy Partner for IMCIVREE Distribution
Mar 20 2026
Newsfilter
Show More News
